Skip to main content
. Author manuscript; available in PMC: 2019 May 9.
Published in final edited form as: Vaccine. 2017 May 25;35(29):3655–3660. doi: 10.1016/j.vaccine.2017.05.041

Table 2.

Incidence rates, rate differences (RD), and rate ratios (RR) of infant outcomes associated with receipt of Tdap during pregnancy at 7 Vaccine Safety Datalink sites, 2010–2013, (N = 197,564), by time period during pregnancy in which Tdap was administered and limiting results to infants born < 34 weeks gestation.

Maternal Tdap administration during pregnancy at any time during pregnancy, 2010–2013
Adjusted measures of association 95% CI
No (n = 152,556)
Yes (n = 45,008)

n Incidence rate % n Incidence rate % RD in cases per 100 live births RR
Chorioamnionitis 7970 5.22 2883 6.41 1.16 (0.9, 1.42) 1.23 (1.17, 1.28)
Composite outcome 4824 3.16 1288 2.86 0.11 (−0.07, 0.29) 1.04 (0.98, 1.11)
TTNa 3524 2.31 973 2.16 0.07 (−0.09, 0.22) 1.03 (0.96, 1.11)
Neonatal sepsisb 939 0.62 231 0.51 0.03 (−0.05, 0.10) 1.06 (0.91, 1.23)
Pneumoniac 371 0.24 73 0.16 0.00 (−0.04, 0.04) 0.94 (0.72, 1.22)
RDSd 215 0.14 49 0.11 −0.01 (−0.05, 0.03) 0.91 (0.66, 1.26)
Convulsions in newborne 261 0.17 68 0.15 0.02 (−0.02, 0.06) 1.16 (0.87, 1.53)
Maternal Tdap administration during recommended time period of pregnancy, 27–36 weeks, 2010–2013
No (n = 133,882)
Yes (n = 22,772)
n Incidence rate % n Incidence rate % RD in cases per 100 live births RR

Chorioamnionitis 7109 5.31 1430 6.28 0.98 (0.65,1.32) 1.20 (1.14, 1.28)
Composite outcome 4157 3.10 653 2.87 0.13 (−0.11, 0.37) 1.02 (0.94, 1.12)
TTN 3061 2.29 520 2.28 0.20 (−0.02, 0.41) 1.08 (0.98, 1.19)
Neonatal sepsis 785 0.59 101 0.44 −0.01 (−0.11, 0.08) 0.90 (0.73, 1.11)
Pneumonia 329 0.25 34 0.15 −0.01 (−0.06, 0.05) 0.82 (0.57, 1.17)
RDS 168 0.13 21 0.09 −0.02 (−0.06, 0.03) 0.79 (0.50, 1.26)
Convulsions in newborn 229 0.17 28 0.12 −0.01 (−0.06, 0.04) 0.88 (0.58, 1.31)
Maternal Tdap administration at any time during pregnancy, infants born < 34 weeks GA
No (n = 2711)
Yes (n = 426)
n Incidence rate % n Incidence rate % RD in cases per 100 live births RR

Chorioamnionitis 221 8.15 28 6.57 −1.02 (−3.51, 1.47) 0.87 (0.59, 1.30)
Composite outcome 695 25.64 104 24.41 0.18 (−4.20, 4.57) 1.02 (0.83, 1.26)
TTN 291 10.73 51 11.97 0.84 (−2.48, 4.15) 1.07 (0.79, 1.45)
Neonatal sepsis 318 11.73 48 11.27 0.85 (−2.22, 3.93) 1.11 (0.81, 1.51)
Pneumonia 121 4.46 9 2.11 −0.95 (−2.76, 0.86) 0.60 (0.30, 1.19)
RDS 46 1.70 5 1.17 −0.26 (−1.59, 1.07) 0.84 (0.33, 2.14)
Convulsions in newborn 40 1.48 5 1.17 −0.12 (−1.49, 1.24) 0.98 (0.38, 2.50)

TTN = transient tachypnea of the newborn; RDS = respiratory distress syndrome.

a

ICD-9 code 770.6.

b

ICD-9 codes 771.8, 771.81, 995.92, & 771.89.

c

ICD-9 codes 770.0 & 480.0–486.

d

ICD-9 codes 769, 770.84, & 770.87.

e

ICD-9 code 779.